Correction to: Considerations for Updates to ICH Q1 and Q5C Stability Guidelines: Embracing Current Technology and Risk Assessment Strategies

Affiliations

• ¹ Pfizer Inc., Eastern Point Road, Groton, Connecticut, 06340, USA. megan.mcmahon@pfizer.com.
• ² Oral Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Silk Road Business Park, Macclesfeld, Cheshire, SK10 2NA, UK.
• ³ Eli Lilly & Company, Lilly Corporate Center, Indianapolis, Indiana, 46285, USA.
• ⁴ Takeda Pharmaceuticals Inc., 40 Landsdowne Street, Cambridge, Massachusetts, 02139, USA.
• ⁵ Pfizer Inc., 8455 Colesville Rd, Silver Spring, Maryland, 20910, USA.
• ⁶ Janssen R&D A Division of Janssen Pharmaceutica NV, Turnhoutseweg 302340, Beerse, Belgium.
• ⁷ Sunovion Pharmaceutical Inc., 84 Waterford Drive, Marlborough, Massachusetts, 01752, USA.
• ⁸ Amgen Ltd., 1 Uxbridge Business Park, Sanderson Road, Uxbridge, UB8 1DH, UK.
• ⁹ Vertex Pharmaceuticals, 50 Northern Avenue, Boston, Massachusetts, 02210, USA.
• ¹⁰ Bristol Myers Squibb, 1 Squibb Drive, New Brunswick, New Jersey, 08903, USA.
• ¹¹ Seagen Inc., 21823 30th Drive SE, Bothell, Washington, 98021, USA.
• ¹² GlaxoSmithKline, Great West Road, Brentford, TW8 9GS, Middlesex, UK.
• ¹³ Boehringer Ingelheim, 900 Ridgebury Road, Ridgefeld, Connecticut, 06877, USA.
• ¹⁴ AbbVie, 1 N Waukegan Road, North Chicago, Illinois, 60064, USA.
• ¹⁵ Pfizer Inc., Eastern Point Road, Groton, Connecticut, 06340, USA.
• ¹⁶ , 225 Binney Street, Cambridge, Massachusetts, USA.
• ¹⁷ , Merck & Co., 2000 Galloping Hill Road, Kenilworth, New Jersey, 07033, USA.